文献速递乳房整形与再造创面修复

经前哨淋巴结切口行放疗后二期假体乳房再造

Use of Sentinel Lymph Node Incision for Second Stage Implant-Based Breast Reconstruction After Radiation.
PubMed 文献 · Ann Plast Surg · 2020-01-01

该回顾性队列研究比较了经前哨淋巴结切口与经乳房前皮肤切口行二期扩张器置换假体的结局。41例匹配对照的总并发症率为41.4%,轻微并发症显著更多(P=0.037)。结论支持经前哨淋巴结切口行二期假体置入,可减少术后轻微并发症。

要点

  • 经前哨淋巴结切口行二期假体置换,术后并发症率10.5%。
  • 匹配对照经乳房前皮肤切口,总并发症率41.4%,轻微并发症显著更多(P=0.037)。
  • 前哨淋巴结切口远离放疗野,利于乳房假体腔隙的分层闭合。

核心结论

  • 数据支持在即刻扩张器置入及辅助放疗后,利用原有腋窝前哨淋巴结切口行二期凝胶假体置入。
  • 经前哨淋巴结切口可远离受照射组织进行分层闭合,降低术后轻微并发症发生率。

研究设计与样本

  • 回顾性队列研究,基于前瞻性维护数据库,纳入完成全乳放疗6个月及以上行二期扩张器置换假体的连续患者。
  • 所有患者放疗后皮肤改变为RTOG/EORTC晚期放射损伤评分皮肤器官系统1级或2级。

主要发现

  • 前哨淋巴结切口组无术中并发症,术后并发症2例(10.5%),平均随访9个月:1例血肿需手术探查,1例轻微伤口需在门诊重新闭合。
  • 病例匹配对照组术后轻微并发症显著更多(P=0.037),总并发症率为41.4%。
  • 对照组中31.7%的患者仅发生轻微并发症,9.7%发生重大并发症。

临床怎么用

  • 对即刻扩张器置入后接受辅助放疗、皮肤改变为RTOG/EORTC 1–2级的患者,二期假体置换可考虑经原前哨淋巴结切口入路。
  • 该入路可避免经受照射的乳房前皮肤切口,可能减少术后轻微并发症。

局限性

  • 为回顾性研究,尽管采用病例匹配,仍可能存在混杂。
  • 包膜挛缩率等长期结局尚待 forthcoming 长期数据确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Staged expander to implant breast reconstruction is associated with a high complication rate when the patient has had postmastectomy radiation. With an increasing number of American women undergoing implant-based breast reconstruction after postmastectomy radiation, surgeons may find themselves operating in a radiated field with synthetic devices. We report the performance characteristics of a novel surgical modification to the second stage expander to implant exchange after adjuvant radiation using a transaxillary approach through a prior sentinel lymph node incision, a site remote from the breast implant pocket. METHODS: We performed a retrospective review of a prospectively maintained database to evaluate the surgical outcomes of serial patients undergoing second staged expander to implant exchange through the sentinel lymph node incision 6 months or more after completing whole breast radiation. A case matched cohort to age, body mass index, and comorbid status was used to compare outcomes between patients in the group of interest versus a traditional skin sparing incision on the anterior breast mound through the radiated skin envelope. All patients included demonstrated grade 1 or 2 skin changes on the Radiation Therapy Oncology Group/European Organization for Research and Treatment of Cancer Late Radiation Morbidity Scoring Schema for the skin organ system. RESULTS: Nineteen breasts were reconstructed for 18 women after immediate tissue expander placement and adjuvant whole breast radiation were included in our group of interest. Forty-one case-matched second controls were identified for the comparison group. There were no intraoperative complications. Two postoperative complications were reported for the sentinel lymph node approach group (10.5%) with an average of 9 months of follow-up: 1 operative exploration for hematoma and 1 minor wound requiring recloser in the office. The case matched cohort demonstrated significantly more minor postoperative complications (P = 0.037) with a total complications rate of 41.4%. There were 31.7% of the patients that experienced a minor complication alone, whereas 9.7% of the case-matched cohort experienced a major complication. CONCLUSIONS: These data support the use of the existing axillary sentinel lymph node access incision for second stage placement of a gel implant after immediate expander and adjuvant radiation therapy. The sentinel lymph node incision approach facilitates layered closure over the breast pocket at a site remote from irradiated tissue, reducing the incidence of postoperative minor complications. Forthcoming long-term data will determine if differences in reported capsular contracture rates can be achieved with a remote transaxillary approach to second stage implant reconstruction after radiation.

来源:Ann Plast Surg,查看原文。版权归原作者所有。

引用

  1. Lobb DC, Deal AL, Campbell CA, et al. Use of Sentinel Lymph Node Incision for Second Stage Implant-Based Breast Reconstruction After Radiation. Ann Plast Surg. 2020. PMID: 32049758. doi:10.1097/SAP.0000000000002270

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。